A novel stage-specific glycosomal nucleoside diphosphate kinase from Trypanosoma cruzi.

CLAUDIO A. PEREIRA; CHANTAL REIGADA; CLAUDIO A. PEREIRA; CHANTAL REIGADA; FABIO A. DIGIROLAMO; MARÍA DE LOS MILAGROS CÁMARA; FABIO A. DIGIROLAMO; MARÍA DE LOS MILAGROS CÁMARA; MELISA SAYÉ; LEÓN BOUVIER; MELISA SAYÉ; LEÓN BOUVIER

FOLIA PARASITOLOGICA

FOLIA PARASITOLOGICA

Año: 2017

0015-5683

Nucleoside diphosphate kinases (NDPK) are key enzymes involved in the intracellular nucleotide maintenance in all livingorganisms, especially in trypanosomatids which are unable to synthesise purines de novo. Four putative NDPK isoforms were identifiedin the Trypanosoma cruzi Chagas, 1909 genome but only two of them were characterised so far. In this work, we studied a novel isoformfrom T. cruzi called TcNDPK3. This enzyme presents an atypical N-terminal extension similar to the DM10 domains. In T. cruzi,DM10 sequences targeted other NDPK isoform (TcNDPK2) to the cytoskeleton, but TcNDPK3 was localised in glycosomes despitelacking a typical peroxisomal targeting signal. In addition, TcNDPK3 was found only in the bloodstream trypomastigotes where glycolyticenzymes are very abundant. However, TcNDPK3 mRNA was also detected at lower levels in amastigotes suggesting regulation atprotein and mRNA level. Finally, 33 TcNDPK3 gene orthologs were identified in the available kinetoplastid genomes. The characterisationof new glycosomal enzymes provides novel targets for drug development to use in therapies of trypanosomatid associated diseases.